Ad is loading...
DCREX
Price
$13.38
Change
+$0.10 (+0.75%)
Updated
Nov 21 closing price
VGSNX
Price
$20.94
Change
+$0.14 (+0.67%)
Updated
Nov 21 closing price
Ad is loading...

DCREX vs VGSNX

Header iconDCREX vs VGSNX Comparison
Open Charts DCREX vs VGSNXBanner chart's image
Dunham Real Estate Stock C
Price$13.38
Change+$0.10 (+0.75%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$20.94
Change+$0.14 (+0.67%)
VolumeN/A
CapitalizationN/A
DCREX vs VGSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DCREX vs. VGSNX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCREX is a StrongBuy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 68.9B vs. DCREX (46.7M). VGSNX pays higher dividends than DCREX: VGSNX (4.01) vs DCREX (1.69). DCREX was incepted earlier than VGSNX: DCREX (20 years) vs VGSNX (21 years). DCREX is a more actively managed with annual turnover of: 73.00 vs. VGSNX (9.00). DCREX has a lower initial minimum investment than VGSNX: DCREX (5000) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 25.16 vs. DCREX (23.37). VGSNX return over 5 years is better than : 25.99 vs. DCREX (-19.96).
DCREXVGSNXDCREX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years21 years-
Gain YTD10.94511.32897%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets46.7M68.9B0%
Annual Yield % from dividends1.694.0142%
Returns for 1 year23.3725.1693%
Returns for 3 years-29.02-1.262,312%
Returns for 5 years-19.9625.99-77%
Returns for 10 years-24.8268.92-36%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCPH3.460.10
+2.98%
scPharmaceuticals
NDSN256.584.02
+1.59%
Nordson Corp
XENE39.800.46
+1.17%
Xenon Pharmaceuticals
RLAY4.64-0.02
-0.43%
Relay Therapeutics
AEI1.10-0.05
-4.35%
Alset